Media coverage
11
Media coverage
Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Business Wire Country/Territory United States Date 18/09/24 URL www.businesswire.com/news/home/20240918328082/en/Peer-Reviewed-Study-bioAffinity-Technologies%E2%80%99-CyPath%C2%AE-Lung-Test-Shows-Potential-Significant-Healthcare-Savings-by-Reducing-Unnecessary-Follow-Up-Medical-Complications-and-Overdiagnosis/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw== Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet ADVFN UK Country/Territory United Kingdom Date 18/09/24 URL https://uk.advfn.com/stock-market/NASDAQ/BIAF/share-news/Peer-Reviewed-Study-bioAffinity-Technologies-Cy/94570336 Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet StockTitan.net Country/Territory United States Date 18/09/24 URL https://www.stocktitan.net/news/BIAF/peer-reviewed-study-bio-affinity-technologies-cy-path-r-lung-test-5bjkjsy9y3pv.html Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Yahoo! Finance Country/Territory United States Date 18/09/24 URL https://finance.yahoo.com/news/peer-reviewed-study-bioaffinity-technologies-120000589.html Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet ADVFN US Country/Territory United States Date 18/09/24 URL https://www.advfn.com/stock-market/NASDAQ/BIAF/stock-news/94570336/peer-reviewed-study-bioaffinity-technologies-cypath-lung-test-shows-potentia Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies' CyPath(TM) Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Stockwatch Country/Territory Canada Date 18/09/24 URL www.stockwatch.com/News/Item/U-b20240918328082-U!BIAF-20240918/U/BIAF Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet BioSpace Country/Territory United States Date 18/09/24 URL https://www.biospace.com/press-releases/peer-reviewed-study-bioaffinity-technologies-cypath-lung-test-shows-potential-significant-healthcare-savings-by-reducing-unnecessary-follow-up-medical-complications-and-overdiagnosis Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies' CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis; Study by BAMC's Michael Morris, M.D., and VA's Sheila Habib, M.D., Media name/outlet Business Wire Country/Territory United States Date 18/09/24 Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet APNews.com Country/Territory United States Date 18/09/24 URL https://apnews.com/press-release/business-wire/medical-technology-lung-cancer-medical-research-texas-3890395562d946c7a37b49b16dd6b7da Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies' CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Le Lezard.com Country/Territory Canada Date 18/09/24 URL https://www.lelezard.com/en/news-21529232.html Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Valdosta Daily Times Country/Territory Georgia Date 18/09/24 URL https://www.valdostadailytimes.com/ap/business/peer-reviewed-study-bioaffinity-technologies-cypath-lung-test-shows-potential-significant-healthcare-savings-by-reducing/article_0c47c948-c399-55a1-bfa8-c19f486b6178.html Persons Michael Morris